Beth Israel Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1890-01-01

Employees: -

Market Cap: -

Website: http://www.bethisraelny.org/

Clinical Trials

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Not Applicable

Terminated

Conditions: Malignant Glioma
Brain Tumors
Glioblastoma
Anaplastic Astrocytoma

Interventions: Radiation: Stem Cell Radiotherapy (ScRT) and Temozolomide

First Posted Date: 2014-01-20

Last Posted Date: 2017-06-05

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 4

Registration Number: NCT02039778

Locations: 🇺🇸
Roosevelt Hospital, New York, New York, United States

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Phase 2

Terminated

Conditions: Non-small Cell Lung Cancer Stage IIIB/IV
Nonsquamous Nonsmall Cell Neoplasm of Lung
Non-small Cell Lung Cancer Metastatic

Interventions: Drug: metformin
Behavioral: carbohydrate restricted diet

First Posted Date: 2013-12-24

Last Posted Date: 2018-05-04

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 14

Registration Number: NCT02019979

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States
🇺🇸
Beth Israel Comprehensive Cancer Center, New York, New York, United States
🇺🇸
Mount Sinai Ichan School of Medicine, New York, New York, United States

and more 1 locations

Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery

Phase 3

Completed

Conditions: Postoperative Pain

Interventions: Other: Saline
Drug: Lidocaine
Drug: Ketamine

First Posted Date: 2013-11-13

Last Posted Date: 2017-05-15

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 46

Registration Number: NCT01983020

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients

Not Applicable

Completed

Conditions: Pain

Interventions: Device: non-invasive transcranial direct current stimulation (tDCS)

First Posted Date: 2013-09-23

Last Posted Date: 2014-07-14

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 24

Registration Number: NCT01948050

Locations: 🇺🇸
Beth Isael Medical Center, New York, USA, New York, United States

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Completed

Conditions: Myelodysplasia
Immune Thrombocytopenia
Aplastic Anaemia
Chemotherapy Induced Thrombocytopenia

Interventions: Other: Hypo-proliferative thrombocytopenics
Other: Immune Thrombocytopenics
Other: Control Population

First Posted Date: 2013-08-30

Last Posted Date: 2016-05-17

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 50

Registration Number: NCT01933035

Locations: 🇺🇸
Roosevelt Hospital, New York, New York, United States

A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder

Not Applicable

Completed

Conditions: Bi-polar II Disorder

Interventions: Device: Active CES
Device: Sham CES

First Posted Date: 2013-07-26

Last Posted Date: 2015-12-24

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 16

Registration Number: NCT01909011

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement

Not Applicable

Withdrawn

Conditions: Need for IV Access

Interventions: Device: Long axis IV placement with ultrasound
Device: Short axis IV placement with ultrasound

First Posted Date: 2013-06-06

Last Posted Date: 2014-06-25

Lead Sponsor: Beth Israel Medical Center

Registration Number: NCT01870661

Locations: 🇺🇸
Beth Isreal Medical Center, New York, New York, United States

Adaptive Radiation Therapy for Head & Neck Cancer Patients

Not Applicable

Completed

Conditions: Cancer of Head and Neck

Interventions: Radiation: concurrent chemo + IGRT
Radiation: neoadjuvant chemo + IGRT

First Posted Date: 2013-05-15

Last Posted Date: 2015-03-30

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 6

Registration Number: NCT01853670

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain

Phase 2

Terminated

Conditions: Facial Pain

Interventions: Device: tDCS

First Posted Date: 2013-05-09

Last Posted Date: 2015-12-10

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 21

Registration Number: NCT01849796

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

Efficacy of Ultrasound to Guide Management During a Rapid Response Event

Not Applicable

Completed

Conditions: Hemodynamic Instability
Respiratory Failure

Interventions: Other: Ultrasound

First Posted Date: 2013-04-24

Last Posted Date: 2014-12-31

Lead Sponsor: Beth Israel Medical Center

Target Recruit Count: 200

Registration Number: NCT01838343

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy